An Autopsy Study of Cerebrovascular Atherosclerosis in the Elderly

Asha S Shenoy1, Mayur N Bhosale1, Gayathri P Amonkar1

  • 1Department of Pathology, T.N. Medical College and B.Y.L. Nair Hospital, Bombay Central, Mumbai, Maharashtra, India.

Neurology India
|December 20, 2022
PubMed

Insights

Intracranial atherosclerosis is more prevalent in the Indian population, particularly affecting the anterior circulation. This contrasts with Western populations, highlighting geographical variations in stroke risk factors.

Area of Science:

  • Neurology
  • Vascular Medicine
  • Epidemiology

Background:

  • Stroke is a leading cause of mortality globally.
  • Intracranial atherosclerosis is a significant risk factor for stroke.
  • Geographical variations in atherosclerosis patterns are documented, with differing prevalence in various ethnic groups.

Purpose of the Study:

  • To investigate the incidence, severity, distribution, plaque composition, and risk factors of intracranial atherosclerosis in Indian elderly patients.
  • To compare atherosclerotic pathology in intracranial and extracranial (carotid) vessels within this population.

Main Methods:

  • Prospective study of 50 Indian patients over 60 years of age.
  • Detailed analysis of the central nervous system (CNS) vasculature, including intracranial arteries.
  • Comparison of intracranial and carotid artery atherosclerosis.

Main Results:

  • 31 out of 50 patients exhibited intracranial atherosclerosis, predominantly affecting the anterior circulation.
  • Fibrofatty plaques were most common, with mild stenosis observed in most intracranial vessels.
  • Carotid artery atherosclerosis was present in 59% of cases, with predominantly fatty plaques.

Conclusions:

  • The pattern of atherosclerosis in the Indian population differs from Western populations.
  • Intracranial atherosclerosis is more common in Indians, with a predilection for the anterior Circle of Willis.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
26
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
34
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
24
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
19